Advicor® (niacin extended-release/lovastatin) Tablets are indicated for the treatment of hypercholesterolemia. Indicated as an adjunct to diet when response ...
More ALTOPREV® (lovastatin) Extended-Release Tablets is an HMG-CoA reductase inhibitor used in addition to a diet restricted in saturated fat and cholesterol as ...
More CRESTOR® (rosuvastatin calcium) is an HMG-CoA reductase inhibitor indicated as an adjunct to diet to reduce elevated total-C, LDL-C, ApoB, nonHDL-C and TG ...
More Lescol® (fluvastatin sodium) Capsules are water-soluble, cholesterol-lowering agents acting through the inhibition of HMG-CoA reductase. Recommended initial ...
More Lescol® XL (fluvastatin sodium) Extended-Release Tablets are water-soluble cholesterol lowering agents acting through the inhibition of HMG-CoA reductase. ...
More LIPITOR® (atorvastatin calcium) Tablets are synthetic lipid-lowering agents (HMG-CoA reductase inhibitor). Recommended starting dose: 10mg or 20mg once ...
More LOPID® (gemfibrozil) Tablets, USP are lipid-regulating agents that decreases serum triglycerides and very low density lipoprotein VLDL cholesterol, and ...
More MEVACOR® (lovastatin) is a HMG-CoA reductase inhibitor isolated from a strain of Aspergillus terreus. Usual recommended starting dose: 20mg once daily with ...
More NIASPAN® (niacin) Extended-Release Tablets are indicated as an adjunct to diet when response to a diet restricted in saturated fat, cholesterol and other ...
More PRAVACHOL® (pravastatin sodium) Tablets are HMC-CoA reductase inhibitors indicated as an adjunct to diet to reduce elevated Total-C, LDL-C, ApoB, and TG ...
More Prevalite® (Cholestyramine for Oral Suspension, USP) is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients ...
More Simcor® (simvastatin/niacin) Extended-Release Tablet is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and ...
More TRICOR® (fenofibrate tablets) is a lipid-regulating agent indicated as adjunct to diet for treatment of hypercholesterolemia (primary hypercholesterolemia ...
More Trilipix™ (fenofibric acid) Capsule, Delayed Release For Oral Use is indicated as adjunct to diet as combination therapy with statins for patients with ...
More VYTORIN® (ezetimibe/simvastatin) Tablets contain two lipid-lowering compounds with complementary mechanisms of action. Reduces elevated total cholesterol ...
More WelChol® (colesevelam hydrochloride) Tablets are indicated as adjunctive therapy to diet and exercise for the reduction of elevated LDL cholesterol in ...
More ZETIA® (ezetimibe) Tablets are indicated as adjunctive therapy to diet for the reduction of elevated sitoserol and campesterol levels in patients with ...
More ZOCOR® (simvastatin) Tablets are lipid-lowering agents that is derived synthetically from a fermentation product of Aspergillus terreus. Recommended usual ...
More
